Thomas Steyer Farallon Capital Management
Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$207M |
| 2 |
ANSS
Ansys
ANSS
|
+$201M |
| 3 |
Woodward
WWD
|
+$192M |
| 4 |
SWN
Southwestern Energy Company
SWN
|
+$168M |
| 5 |
SQSP
Squarespace, Inc.
SQSP
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$294M |
| 2 |
Nasdaq
NDAQ
|
+$256M |
| 3 |
Salesforce
CRM
|
+$231M |
| 4 |
AstraZeneca
AZN
|
+$188M |
| 5 |
Aramark
ARMK
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.84% |
| 2 | Technology | 13.48% |
| 3 | Financials | 9.84% |
| 4 | Communication Services | 6.79% |
| 5 | Industrials | 6.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Airbnb
ABNB
$110B
| $301M | 1.32% |
2,371,200
+670,200
| +39% | +$86.9M |
|
27
PUT
iShares Biotechnology ETF
IBB
$10.7B
| $291M | 1.28% |
2,000,000
-1,500,000
| -43% | -$217M |
|
|
ANSS
28
DELISTED
Ansys
ANSS
| $283M | 1.24% |
888,000
+633,000
| +248% | +$201M |
|
|
29
Nasdaq
NDAQ
$54.9B
| $275M | 1.21% |
3,762,271
-3,744,448
| -50% | -$256M |
|
30
ServiceNow
NOW
$133B
| $264M | 1.16% |
1,475,250
-795,000
| -35% | -$131M |
|
31
Protagonist Therapeutics
PTGX
$9.99B
| $264M | 1.16% |
5,861,006
+20,233
| +0.3% | +$817K |
|
32
Agios Pharmaceuticals
AGIO
$1.98B
| $252M | 1.1% |
5,660,866
+6,364
| +0.1% | +$289K |
|
33
Mastercard
MA
$509B
| $250M | 1.1% |
506,671
+43,900
| +9% | +$20.4M |
|
34
S&P Global
SPGI
$127B
| $246M | 1.08% |
475,334
-306,600
| -39% | -$152M |
|
35
PUT
Moderna
MRNA
$57.9B
| $234M | 1.03% |
3,500,000
+2,200,000
| +169% | +$202M |
|
36
PUT
iShares Russell 2000 ETF
IWM
$81.9B
| $221M | 0.97% |
1,000,000
-3,250,000
| -76% | -$695M |
|
37
Sherwin-Williams
SHW
$84.1B
| $212M | 0.93% |
555,950
-91,600
| -14% | -$32M |
|
38
Visa
V
$693B
| $207M | 0.91% |
752,010
-69,876
| -9% | -$18.9M |
|
39
Beam Therapeutics
BEAM
$3.07B
| $201M | 0.88% |
8,208,123
+295,000
| +4% | +$7.62M |
|
|
40
Woodward
WWD
$20.3B
| $198M | 0.87% |
+1,154,000
| New | +$192M |
|
41
New Oriental
EDU
$8.88B
| $192M | 0.84% |
2,533,600
+1,064,010
| +72% | +$72.9M |
|
|
SRCL
42
DELISTED
Stericycle Inc
SRCL
| $192M | 0.84% |
3,146,000
+586,000
| +23% | +$34.8M |
|
43
Full Truck Alliance
YMM
$9.1B
| $186M | 0.82% |
20,665,548
-5,184,755
| -20% | -$39.8M |
|
|
SWN
44
DELISTED
Southwestern Energy Company
SWN
| $185M | 0.81% |
+25,993,099
| New | +$168M |
|
45
Biohaven
BHVN
$2.09B
| $182M | 0.8% |
3,642,589
+1,394,589
| +62% | +$54.3M |
|
|
MASI
46
DELISTED
Masimo
MASI
| $168M | 0.74% |
1,258,563
+139,000
| +12% | +$16.1M |
|
47
Howmet Aerospace
HWM
$108B
| $152M | 0.67% |
1,514,339
-1,027,500
| -40% | -$92.8M |
|
|
HCP
48
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $151M | 0.66% |
4,445,000
-1,460,000
| -25% | -$49.2M |
|
|
AMED
49
DELISTED
Amedisys
AMED
| $145M | 0.64% |
1,500,000
+191,500
| +15% | +$18.7M |
|
|
SQSP
50
DELISTED
Squarespace, Inc.
SQSP
| $134M | 0.59% |
+2,891,632
| New | +$130M |
|
Similar funds
Thomas Steyer's Q3 2024 Portfolio in Review
As of Q3 2024, Thomas Steyer held 187 positions worth $22.8B, down 2.2% from $23.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Thomas Steyer withdrew a net $2.26B in Q3 2024, closing 22 positions and reducing 39 holdings. Its most notable exit was AstraZeneca, an estimated $188M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Thomas Steyer opened a new position in Woodward worth $198M.
- Thomas Steyer's largest Q3 2024 buy was Woodward: 1,154,000 shares worth $198M.
- Thomas Steyer added most to Walt Disney in Q3 2024, an estimated $207M increase.
- Thomas Steyer's biggest Q3 2024 reduction was UnitedHealth, cutting an estimated $294M.
- Thomas Steyer fully exited AstraZeneca in Q3 2024, selling an estimated $188M.
- Thomas Steyer's ten largest holdings make up 40% of its $22.8B portfolio in Q3 2024.
- Thomas Steyer opened 21 new positions and closed 22 in Q3 2024.
- Thomas Steyer's portfolio value fell 2.2% quarter-over-quarter to $22.8B.
Based on Farallon Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.